Loading…
Defining estimands in clinical trials: A unified procedure
The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regula...
Saved in:
Published in: | Statistics in medicine 2023-05, Vol.42 (12), p.1869-1887 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703 |
---|---|
cites | cdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703 |
container_end_page | 1887 |
container_issue | 12 |
container_start_page | 1869 |
container_title | Statistics in medicine |
container_volume | 42 |
creator | Han, Shasha Zhou, Xiao‐Hua |
description | The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials. |
doi_str_mv | 10.1002/sim.9702 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2784839460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2814261914</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</originalsourceid><addsrcrecordid>eNp1kMlKA0EQhhtRTIyCTyADXrxM7GV6mdxC3AIRD-q56W2kwyyxO4Pk7e2YqCB4Kqj6-KrqB-AcwTGCEF9H34xLDvEBGCJY8hxiKg7BEGLOc8YRHYCTGJcQIkQxPwYDwoQgjIghmNy4yre-fctcXPtGtTZmvs1MnZpG1dk6eFXHSTbN-tZX3tlsFTrjbB_cKTiq0syd7esIvN7dvswe8sXT_Xw2XeSGCIJzTLmjDGurhKiMIdQSYSBWxFqhCsNKrZ3ThGllMacUa6wpQbbUuOQOckhG4GrnTZvf-3SmbHw0rq5V67o-SsxFIUhZsC16-Qdddn1o03USC1RghkpU_ApN6GIMrpKrkF4PG4mg3OYpU55ym2dCL_bCXjfO_oDfASYg3wEfvnabf0Xyef74JfwEv8Z9Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2814261914</pqid></control><display><type>article</type><title>Defining estimands in clinical trials: A unified procedure</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Han, Shasha ; Zhou, Xiao‐Hua</creator><creatorcontrib>Han, Shasha ; Zhou, Xiao‐Hua</creatorcontrib><description>The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials.</description><identifier>ISSN: 0277-6715</identifier><identifier>EISSN: 1097-0258</identifier><identifier>DOI: 10.1002/sim.9702</identifier><identifier>PMID: 36883638</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>causal inference ; clinical trials ; Data Collection ; Data Interpretation, Statistical ; estimands ; Humans ; intercurrent events ; Models, Statistical ; post‐treatment variables ; Research Design</subject><ispartof>Statistics in medicine, 2023-05, Vol.42 (12), p.1869-1887</ispartof><rights>2023 John Wiley & Sons Ltd.</rights><rights>2023 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</citedby><cites>FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</cites><orcidid>0000-0001-7935-1222 ; 0000-0001-7388-8125</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36883638$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Shasha</creatorcontrib><creatorcontrib>Zhou, Xiao‐Hua</creatorcontrib><title>Defining estimands in clinical trials: A unified procedure</title><title>Statistics in medicine</title><addtitle>Stat Med</addtitle><description>The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials.</description><subject>causal inference</subject><subject>clinical trials</subject><subject>Data Collection</subject><subject>Data Interpretation, Statistical</subject><subject>estimands</subject><subject>Humans</subject><subject>intercurrent events</subject><subject>Models, Statistical</subject><subject>post‐treatment variables</subject><subject>Research Design</subject><issn>0277-6715</issn><issn>1097-0258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1kMlKA0EQhhtRTIyCTyADXrxM7GV6mdxC3AIRD-q56W2kwyyxO4Pk7e2YqCB4Kqj6-KrqB-AcwTGCEF9H34xLDvEBGCJY8hxiKg7BEGLOc8YRHYCTGJcQIkQxPwYDwoQgjIghmNy4yre-fctcXPtGtTZmvs1MnZpG1dk6eFXHSTbN-tZX3tlsFTrjbB_cKTiq0syd7esIvN7dvswe8sXT_Xw2XeSGCIJzTLmjDGurhKiMIdQSYSBWxFqhCsNKrZ3ThGllMacUa6wpQbbUuOQOckhG4GrnTZvf-3SmbHw0rq5V67o-SsxFIUhZsC16-Qdddn1o03USC1RghkpU_ApN6GIMrpKrkF4PG4mg3OYpU55ym2dCL_bCXjfO_oDfASYg3wEfvnabf0Xyef74JfwEv8Z9Fw</recordid><startdate>20230530</startdate><enddate>20230530</enddate><creator>Han, Shasha</creator><creator>Zhou, Xiao‐Hua</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7935-1222</orcidid><orcidid>https://orcid.org/0000-0001-7388-8125</orcidid></search><sort><creationdate>20230530</creationdate><title>Defining estimands in clinical trials: A unified procedure</title><author>Han, Shasha ; Zhou, Xiao‐Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>causal inference</topic><topic>clinical trials</topic><topic>Data Collection</topic><topic>Data Interpretation, Statistical</topic><topic>estimands</topic><topic>Humans</topic><topic>intercurrent events</topic><topic>Models, Statistical</topic><topic>post‐treatment variables</topic><topic>Research Design</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Shasha</creatorcontrib><creatorcontrib>Zhou, Xiao‐Hua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Statistics in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Shasha</au><au>Zhou, Xiao‐Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining estimands in clinical trials: A unified procedure</atitle><jtitle>Statistics in medicine</jtitle><addtitle>Stat Med</addtitle><date>2023-05-30</date><risdate>2023</risdate><volume>42</volume><issue>12</issue><spage>1869</spage><epage>1887</epage><pages>1869-1887</pages><issn>0277-6715</issn><eissn>1097-0258</eissn><abstract>The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>36883638</pmid><doi>10.1002/sim.9702</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0001-7935-1222</orcidid><orcidid>https://orcid.org/0000-0001-7388-8125</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0277-6715 |
ispartof | Statistics in medicine, 2023-05, Vol.42 (12), p.1869-1887 |
issn | 0277-6715 1097-0258 |
language | eng |
recordid | cdi_proquest_miscellaneous_2784839460 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | causal inference clinical trials Data Collection Data Interpretation, Statistical estimands Humans intercurrent events Models, Statistical post‐treatment variables Research Design |
title | Defining estimands in clinical trials: A unified procedure |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A17%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20estimands%20in%20clinical%20trials:%20A%20unified%20procedure&rft.jtitle=Statistics%20in%20medicine&rft.au=Han,%20Shasha&rft.date=2023-05-30&rft.volume=42&rft.issue=12&rft.spage=1869&rft.epage=1887&rft.pages=1869-1887&rft.issn=0277-6715&rft.eissn=1097-0258&rft_id=info:doi/10.1002/sim.9702&rft_dat=%3Cproquest_cross%3E2814261914%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2814261914&rft_id=info:pmid/36883638&rfr_iscdi=true |